P33527 (MRP1_HUMAN) Homo sapiens (Human)

Multidrug resistance-associated protein 1 UniProtKBInterProSTRINGInteractive Modelling

1531 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9)

Available Structures

2 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Nucleotide-free crystal structure of nucleotide-binding domain 1 from human MRP1 supports a general…monomer641-871
SO4;
Assess
Structure of the human Multidrug Resistance Protein 1 Nucleotide Binding Domain 1monomer642-871
MG;ATP;
Assess

6 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6uy0.1.Amonomer0.77203-1531
ATP;ADP;MG;CLR;90.52
Assess
5uj9.1.Amonomer0.73190-1517
89.93
Assess
8i4a.1.Amonomer0.65204-1529
40.08
Assess
7y1l.1.Amonomer0.64214-1526
38.45
Assess
7w4p.1.Bmonomer0.6430-1525
MG;32.66
Assess
7mit.1.Emonomer0.59136-1523
34.52
Assess

40 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26uy0.1.Amonomer0.75203-1471
MG;CLR;90.75
Assess
Isoform 28f4b.1.Amonomer0.74205-1472
90.92
Assess
Isoform 27w4p.1.Bmonomer0.6330-1468
31.82
Assess
Isoform 36uy0.1.Amonomer0.75203-1474
ATP;MG;CLR;89.41
Assess
Isoform 35uj9.1.Amonomer0.72190-1461
88.47
Assess
Isoform 38jy5.1.Amonomer0.673-1473
45.29
Assess
Isoform 38jxu.1.Amonomer0.6518-1474
47.90
Assess
Isoform 37w4p.1.Bmonomer0.625-1470
MG;31.16
Assess
Isoform 36c3o.1.Hmonomer0.595-1472
MG;31.23
Assess
Isoform 37u1e.1.Emonomer0.585-1467
31.51
Assess
Isoform 46uy0.1.Amonomer0.75203-1465
ADP;CLR;88.49
Assess
Isoform 45uj9.1.Amonomer0.72190-1465
87.32
Assess
Isoform 47w4p.1.Bmonomer0.6231-1465
MG;30.71
Assess
Isoform 47mit.1.Emonomer0.58104-1465
31.94
Assess
Isoform 48ti2.1.Hmonomer0.555-1465
30.54
Assess
Isoform 56uy0.1.Amonomer0.73203-1415
CLR;90.31
Assess
Isoform 58f4b.1.Amonomer0.72205-1416
90.83
Assess
Isoform 58jy5.1.Amonomer0.63700-1414
53.67
Assess
Isoform 58bjf.1.Amonomer0.63205-1410
34.86
Assess
Isoform 57zka.1.Amonomer0.56321-1410
MG;16.96
Assess
Isoform 54lsg.1.Amonomer0.51384-1411
17.20
Assess
Isoform 57zkb.1.Amonomer0.51321-1403
16.96
Assess
Isoform 66uy0.1.Amonomer0.74203-1406
CLR;88.36
Assess
Isoform 65uj9.1.Amonomer0.71190-1406
87.20
Assess
Isoform 67tys.1.Emonomer0.5831-1406
30.11
Assess
Isoform 76uy0.1.Amonomer0.72203-1400
MG;CLR;87.37
Assess
Isoform 78f4b.1.Amonomer0.71205-1400
87.14
Assess
Isoform 78jy5.1.Amonomer0.653-1400
42.99
Assess
Isoform 78jxu.1.Amonomer0.6118-1376
46.17
Assess
Isoform 76c3o.1.Hmonomer0.5630-1400
30.58
Assess
Isoform 86uy0.1.Amonomer0.73203-1348
CLR;88.30
Assess
Isoform 85uj9.1.Amonomer0.70190-1348
87.08
Assess
Isoform 87tys.1.Emonomer0.5630-1347
28.63
Assess
Isoform 86ujr.1.Amonomer0.55313-1343
14.78
Assess
Isoform 96uy0.1.Amonomer0.76203-1541
ATP;ADP;CLR;90.52
Assess
Isoform 95uj9.1.Amonomer0.73190-1527
89.78
Assess
Isoform 98i4a.1.Amonomer0.64204-1539
39.52
Assess
Isoform 97w4p.1.Bmonomer0.6430-1535
MG;32.73
Assess
Isoform 97y1l.1.Amonomer0.64214-1536
38.28
Assess
Isoform 97mit.1.Emonomer0.58136-1533
34.75
Assess